Lehrstuhl für Innere Medizin III

KNEE JOINT PAIN IN AN ELDERLY, HEALTHY POPULATION IS ASSOCIATED WITH INFLAMMATORY ARTICULAR AND ENTHESEAL CHANGES DETECTED BY ULTRASOUND (2019) Simon D, Kleyer A, Adinolfi A, Willeit J, Kiechl S, Gasperi N, Schett G, et al. Conference contribution THE PHYSIOLOGICAL FINGER JOINT ARCHITECTURE - AGE-RELATED INCREASE OF EROSIONS AND OSTEOPHYTES IN THE JOINTS OF HEALTHY INDIVIDUALS (2019) Simon D, Berlin A, Tascilar K, Bayat S, Engelke K, Rech J, Figuereido C, et al. Conference contribution PU.1 INHIBITOR DB1976 CONTROLS FIBROBLAST POLARIZATION IN SYSTEMIC SCLEROSISAND LEADS TO REGRESSION OF FIBROSIS IN DIFFERENT MODELS OF ORGAN FIBROSIS (2019) Wohlfahrt T, Rauber S, Luber M, Soare A, Weber S, Matei AE, Chen CW, et al. Conference contribution FOSL-2 IS A REPRESSOR OF FOXP3 EXPRESSION DURING TREG DEVELOPMENT AND CONTROLS AUTOIMMUNITY (2019) Renoux F, Stellato M, Vogetseder A, Huang R, Subramaniam A, Blyszczuk P, Distler J, et al. Conference contribution SIZE MATTERS - EXTENT OF MONOSODIUM URATE DEPOSITS BUT NOT SERUM URATE LEVEL PREDICTS COMPLETE RESOLUTION OF MONOSODIUM URATE CRYSTAL DEPOSITS IN PATIENTS WITH GOUT (2019) Bayat S, Ellmann H, Guilhon de Araujo E, Manger B, Hagen M, Kleyer A, Lell M, et al. Conference contribution PROFIBROTIC LNCRNA H19X: UNRAVELLING THE EFFECTS ON CHROMATIN REMODELING IN SYSTEMIC SCLEROSIS FIBROBLASTS (2019) Pachera E, Assassi S, Salazar G, Frank-Bertoncelj M, Distler J, Kania G, Distler O Conference contribution HAND FUNCTION IS IMPAIRED IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND PSORIASIS COMPARED TO HEALTHY CONTROLS (2019) Liphardt AM, Liehr S, Manger E, Bieniek L, Kleyer A, Simon D, Tascilar K, et al. Conference contribution JAK-INHIBITORS TOFACITINIB AND BARICITINIB IMPROVE PATHOLOGICAL BONE LOSS IN VIVO (2019) Adam S, Simon N, Steffen U, Harre N, Andes F, Mueller D, Culemann S, et al. Conference contribution COMPARATIVE CHANGE IN QUALITY OF LIFE MEASURES IN PRECLINICAL AND ESTABLISHED PSORIATIC ARTHRITIS PATIENTSUNDER SECUKINUMAB TREATMENT. DATA DERIVED FROM THE PROSPECTIVE OPEN LABEL PSARTROS STUDY (2019) Kampylafka E, Englbrecht M, Tascilar K, Lerchen V, Linz C, Kleyer A, Simon D, et al. Conference contribution RESOLUTION OF VASCULAR INFLAMMATION IN PATIENTS WITH GIANT CELL ARTERITIS RECEIVING GLUCOCORTICOIDS, METHOTREXATE OR TOCILIZUMAB TREATMENT-DATA FROM THE ITALIAN/GERMAN RIGA STUDY (2019) Schonau V, Roth J, Tascilar K, Rech J, Schmidt D, Kuwert T, Crescentini F, et al. Conference contribution